Global Monkeypox Virus Monoclonal Antibody Market growth is projected to reach USD $ Billion in 2025, at a $% CAGR by driving industry size, share, segments research, top company analysis, trends and forecast report 2025 to 2031.

Global Monkeypox Virus Monoclonal Antibody Market Trends and Outlook 2025-31

The global Monkeypox Virus Monoclonal Antibody market size is predicted to grow from US$ 1459 million in 2025 to US$ 2520 million in 2031; it is expected to grow at a CAGR of 9.5% from 2025 to 2031. Monkeypox virus monoclonal antibodies are highly homogeneous antibodies produced by a single B cell clone and target only a specific antigenic epitope of monkeypox virus. United States market for Monkeypox Virus Monoclonal Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Monkeypox Virus Monoclonal Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Monkeypox Virus Monoclonal Antibody is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Monkeypox Virus Monoclonal Antibody players cover ProteoGenix, ACROBiosystems, Creative Diagnostics, Novus Biologicals, LLC, Merck Group, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the ?Monkeypox Virus Monoclonal Antibody Industry Forecast? looks at past sales and reviews total world Monkeypox Virus Monoclonal Antibody sales in 2024, providing a comprehensive analysis by region and market sector of projected Monkeypox Virus Monoclonal Antibody sales for 2025 through 2031. With Monkeypox Virus Monoclonal Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monkeypox Virus Monoclonal Antibody industry. This Insight Report provides a comprehensive analysis of the global Monkeypox Virus Monoclonal Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monkeypox Virus Monoclonal Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Monkeypox Virus Monoclonal Antibody market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monkeypox Virus Monoclonal Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monkeypox Virus Monoclonal Antibody. This report presents a comprehensive overview, market shares, and growth opportunities of Monkeypox Virus Monoclonal Antibody market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Purity>90% &nbsp;&nbsp;&nbsp; Purity>95% &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Diagnostic Laboratories &nbsp;&nbsp;&nbsp; Research and Academic Laboratories &nbsp;&nbsp;&nbsp; Pharmaceutical and Biotechnology Companies This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; ProteoGenix &nbsp;&nbsp;&nbsp; ACROBiosystems &nbsp;&nbsp;&nbsp; Creative Diagnostics &nbsp;&nbsp;&nbsp; Novus Biologicals, LLC &nbsp;&nbsp;&nbsp; Merck Group &nbsp;&nbsp;&nbsp; Absolute Antibody &nbsp;&nbsp;&nbsp; Creative Biolabs &nbsp;&nbsp;&nbsp; Sanyoubio &nbsp;&nbsp;&nbsp; Cnpair &nbsp;&nbsp;&nbsp; Vazyme &nbsp;&nbsp;&nbsp; Sinobiological Key Questions Addressed in this Report What is the 10-year outlook for the global Monkeypox Virus Monoclonal Antibody market? What factors are driving Monkeypox Virus Monoclonal Antibody market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Monkeypox Virus Monoclonal Antibody market opportunities vary by end market size? How does Monkeypox Virus Monoclonal Antibody break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Monkeypox Virus Monoclonal Antibody Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Monkeypox Virus Monoclonal Antibody by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Monkeypox Virus Monoclonal Antibody by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Monkeypox Virus Monoclonal Antibody Segment by Type &nbsp;2.2.1 Purity>90% &nbsp;2.2.2 Purity>95% &nbsp;2.2.3 Others &nbsp;2.3 Monkeypox Virus Monoclonal Antibody Sales by Type &nbsp;2.3.1 Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Monkeypox Virus Monoclonal Antibody Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Monkeypox Virus Monoclonal Antibody Sale Price by Type (2020-2025) &nbsp;2.4 Monkeypox Virus Monoclonal Antibody Segment by Application &nbsp;2.4.1 Diagnostic Laboratories &nbsp;2.4.2 Research and Academic Laboratories &nbsp;2.4.3 Pharmaceutical and Biotechnology Companies &nbsp;2.5 Monkeypox Virus Monoclonal Antibody Sales by Application &nbsp;2.5.1 Global Monkeypox Virus Monoclonal Antibody Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Monkeypox Virus Monoclonal Antibody Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Monkeypox Virus Monoclonal Antibody Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Monkeypox Virus Monoclonal Antibody Breakdown Data by Company &nbsp;3.1.1 Global Monkeypox Virus Monoclonal Antibody Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Monkeypox Virus Monoclonal Antibody Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Monkeypox Virus Monoclonal Antibody Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Monkeypox Virus Monoclonal Antibody Revenue by Company (2020-2025) &nbsp;3.2.2 Global Monkeypox Virus Monoclonal Antibody Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Monkeypox Virus Monoclonal Antibody Sale Price by Company &nbsp;3.4 Key Manufacturers Monkeypox Virus Monoclonal Antibody Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Monkeypox Virus Monoclonal Antibody Product Location Distribution &nbsp;3.4.2 Players Monkeypox Virus Monoclonal Antibody Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Monkeypox Virus Monoclonal Antibody by Geographic Region &nbsp;4.1 World Historic Monkeypox Virus Monoclonal Antibody Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Monkeypox Virus Monoclonal Antibody Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Monkeypox Virus Monoclonal Antibody Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Monkeypox Virus Monoclonal Antibody Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Monkeypox Virus Monoclonal Antibody Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Monkeypox Virus Monoclonal Antibody Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Monkeypox Virus Monoclonal Antibody Sales Growth &nbsp;4.4 APAC Monkeypox Virus Monoclonal Antibody Sales Growth &nbsp;4.5 Europe Monkeypox Virus Monoclonal Antibody Sales Growth &nbsp;4.6 Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales Growth 5 Americas &nbsp;5.1 Americas Monkeypox Virus Monoclonal Antibody Sales by Country &nbsp;5.1.1 Americas Monkeypox Virus Monoclonal Antibody Sales by Country (2020-2025) &nbsp;5.1.2 Americas Monkeypox Virus Monoclonal Antibody Revenue by Country (2020-2025) &nbsp;5.2 Americas Monkeypox Virus Monoclonal Antibody Sales by Type (2020-2025) &nbsp;5.3 Americas Monkeypox Virus Monoclonal Antibody Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Monkeypox Virus Monoclonal Antibody Sales by Region &nbsp;6.1.1 APAC Monkeypox Virus Monoclonal Antibody Sales by Region (2020-2025) &nbsp;6.1.2 APAC Monkeypox Virus Monoclonal Antibody Revenue by Region (2020-2025) &nbsp;6.2 APAC Monkeypox Virus Monoclonal Antibody Sales by Type (2020-2025) &nbsp;6.3 APAC Monkeypox Virus Monoclonal Antibody Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Monkeypox Virus Monoclonal Antibody by Country &nbsp;7.1.1 Europe Monkeypox Virus Monoclonal Antibody Sales by Country (2020-2025) &nbsp;7.1.2 Europe Monkeypox Virus Monoclonal Antibody Revenue by Country (2020-2025) &nbsp;7.2 Europe Monkeypox Virus Monoclonal Antibody Sales by Type (2020-2025) &nbsp;7.3 Europe Monkeypox Virus Monoclonal Antibody Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Monkeypox Virus Monoclonal Antibody by Country &nbsp;8.1.1 Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Monkeypox Virus Monoclonal Antibody Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Monkeypox Virus Monoclonal Antibody Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Monkeypox Virus Monoclonal Antibody &nbsp;10.3 Manufacturing Process Analysis of Monkeypox Virus Monoclonal Antibody &nbsp;10.4 Industry Chain Structure of Monkeypox Virus Monoclonal Antibody 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Monkeypox Virus Monoclonal Antibody Distributors &nbsp;11.3 Monkeypox Virus Monoclonal Antibody Customer 12 World Forecast Review for Monkeypox Virus Monoclonal Antibody by Geographic Region &nbsp;12.1 Global Monkeypox Virus Monoclonal Antibody Market Size Forecast by Region &nbsp;12.1.1 Global Monkeypox Virus Monoclonal Antibody Forecast by Region (2026-2031) &nbsp;12.1.2 Global Monkeypox Virus Monoclonal Antibody Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Monkeypox Virus Monoclonal Antibody Forecast by Type (2026-2031) &nbsp;12.7 Global Monkeypox Virus Monoclonal Antibody Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 ProteoGenix &nbsp;13.1.1 ProteoGenix Company Information &nbsp;13.1.2 ProteoGenix Monkeypox Virus Monoclonal Antibody Product Portfolios and Specifications &nbsp;13.1.3 ProteoGenix Monkeypox Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 ProteoGenix Main Business Overview &nbsp;13.1.5 ProteoGenix Latest Developments &nbsp;13.2 ACROBiosystems &nbsp;13.2.1 ACROBiosystems Company Information &nbsp;13.2.2 ACROBiosystems Monkeypox Virus Monoclonal Antibody Product Portfolios and Specifications &nbsp;13.2.3 ACROBiosystems Monkeypox Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 ACROBiosystems Main Business Overview &nbsp;13.2.5 ACROBiosystems Latest Developments &nbsp;13.3 Creative Diagnostics &nbsp;13.3.1 Creative Diagnostics Company Information &nbsp;13.3.2 Creative Diagnostics Monkeypox Virus Monoclonal Antibody Product Portfolios and Specifications &nbsp;13.3.3 Creative Diagnostics Monkeypox Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 Creative Diagnostics Main Business Overview &nbsp;13.3.5 Creative Diagnostics Latest Developments &nbsp;13.4 Novus Biologicals, LLC &nbsp;13.4.1 Novus Biologicals, LLC Company Information &nbsp;13.4.2 Novus Biologicals, LLC Monkeypox Virus Monoclonal Antibody Product Portfolios and Specifications &nbsp;13.4.3 Novus Biologicals, LLC Monkeypox Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Novus Biologicals, LLC Main Business Overview &nbsp;13.4.5 Novus Biologicals, LLC Latest Developments &nbsp;13.5 Merck Group &nbsp;13.5.1 Merck Group Company Information &nbsp;13.5.2 Merck Group Monkeypox Virus Monoclonal Antibody Product Portfolios and Specifications &nbsp;13.5.3 Merck Group Monkeypox Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Merck Group Main Business Overview &nbsp;13.5.5 Merck Group Latest Developments &nbsp;13.6 Absolute Antibody &nbsp;13.6.1 Absolute Antibody Company Information &nbsp;13.6.2 Absolute Antibody Monkeypox Virus Monoclonal Antibody Product Portfolios and Specifications &nbsp;13.6.3 Absolute Antibody Monkeypox Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Absolute Antibody Main Business Overview &nbsp;13.6.5 Absolute Antibody Latest Developments &nbsp;13.7 Creative Biolabs &nbsp;13.7.1 Creative Biolabs Company Information &nbsp;13.7.2 Creative Biolabs Monkeypox Virus Monoclonal Antibody Product Portfolios and Specifications &nbsp;13.7.3 Creative Biolabs Monkeypox Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Creative Biolabs Main Business Overview &nbsp;13.7.5 Creative Biolabs Latest Developments &nbsp;13.8 Sanyoubio &nbsp;13.8.1 Sanyoubio Company Information &nbsp;13.8.2 Sanyoubio Monkeypox Virus Monoclonal Antibody Product Portfolios and Specifications &nbsp;13.8.3 Sanyoubio Monkeypox Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Sanyoubio Main Business Overview &nbsp;13.8.5 Sanyoubio Latest Developments &nbsp;13.9 Cnpair &nbsp;13.9.1 Cnpair Company Information &nbsp;13.9.2 Cnpair Monkeypox Virus Monoclonal Antibody Product Portfolios and Specifications &nbsp;13.9.3 Cnpair Monkeypox Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Cnpair Main Business Overview &nbsp;13.9.5 Cnpair Latest Developments &nbsp;13.10 Vazyme &nbsp;13.10.1 Vazyme Company Information &nbsp;13.10.2 Vazyme Monkeypox Virus Monoclonal Antibody Product Portfolios and Specifications &nbsp;13.10.3 Vazyme Monkeypox Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Vazyme Main Business Overview &nbsp;13.10.5 Vazyme Latest Developments &nbsp;13.11 Sinobiological &nbsp;13.11.1 Sinobiological Company Information &nbsp;13.11.2 Sinobiological Monkeypox Virus Monoclonal Antibody Product Portfolios and Specifications &nbsp;13.11.3 Sinobiological Monkeypox Virus Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Sinobiological Main Business Overview &nbsp;13.11.5 Sinobiological Latest Developments 14 Research Findings and Conclusion

Report	Global Monkeypox Virus Monoclonal Antibody Market Growth 2025-2031
Selected License	Single ID:LPI8217

Buyer Information

Order Summary